Iodide

Iodide

SCHEMBL1686525

CCCCCCCC[Al+2].[I-].[I-]

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.57
THRB P10828 1/20 0.57
DNM1 Q05193 7/20 0.43
ALDH1A1 P00352 3/20 0.42
LMNA P02545 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
HSD17B10 Q99714 1/20 0.42
SLC22A1 O15245 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL1687038 1.00
Iodide SCHEMBL10455838 1.00 TSHR (0.57) TSHRTHRBDNM1ALDH1A1LMNA
Iodide SCHEMBL8148784 0.96
Fluoride Ion SCHEMBL8150351 0.93
SCHEMBL11589353 0.93 TSHR (0.57) TSHRTHRBDNM1ALDH1A1LMNA
Bromide SCHEMBL1686435 0.93
Fluoride Ion SCHEMBL11773900 0.93 TSHR (0.57) TSHRTHRBDNM1ALDH1A1LMNA
Hydrochloric Acid SCHEMBL6563754 0.93 TSHR (0.57) TSHRTHRBDNM1ALDH1A1LMNA
Hydrochloric Acid SCHEMBL10520281 0.93 TSHR (0.57) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL151384 0.93

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1680394-B Process for producing compound, catalyst component, process for producing catalyst, and process for producing addition polymer SUMITOMO CO LTD 2012-11-21 CN disclosed
US-7932330-B2 Process for producing modified particle; carrier; catalyst component for addition polymerization; process for producing catalyst for addition polymerization; and process for producing addition polymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-04-26 US disclosed
US-7592402-B2 Process for producing modified particle; carrier; catalyst component for addition polymerization; process for producing catalyst for addition polymerization; and process for producing addition polymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-09-22 US disclosed
US-7524789-B2 Process for producing modified particle, carrier or catalyst component for addition polymerization, pre-polymerized catalyst component therefor, catalyst therefor, and addition polymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-04-28 US disclosed
US-20080319148-A1 Process for producing modified particle; carrier; catalyst component for addition polymerization; process for producing catalyst for addition polymerization; and process for producing addition polymer SUMITOMO CHEMICAL COMPANY, LIMITED 2008-12-25 US disclosed
US-7122691-B2 Process for producing compound, catalyst component for addition polymerization, process for producing catalyst for addition polymerization, and process for producing addition polymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-10-17 US disclosed
US-20050245701-A1 Process for producing modified particle; carrier; catalyst component for addition polymerization; process for producing catalyst for addition polymerization; and process for producing addition polymer SUMITOMO CHEMICAL COMPANY, LIMITED 2005-11-03 US disclosed
CN-1680394-A Process for producing compound, catalyst component, process for producing catalyst, and process for producing addition polymer SUMITOMO CHEMICAL CO (JP) 2005-10-12 CN disclosed
US-20050222351-A1 Process for producing compound, catalyst component for addition polymerization, process for producing catalyst for addition polymerization, and process for producing addition polymer SUMITOMO CHEMICAL COMPANY, LIMITED 2005-10-06 US disclosed
US-20050148459-A1 Process for producing modified particle, carrier or catalyst component for addition polymerization, pre-polymerized catalyst component therefor, catalyst therefor, and addition polymer SUMITOMO CHEMICAL COMPANY, LIMITED 2005-07-07 US disclosed
US-5171776-A Crosslinked polymer of dicyclopentadiene produced by metathesis polymerization; adjust heat deflection and glass transition temperature HERCULES INCORPORATED (US) 1992-12-15 US disclosed
US-5055499-A Metathesis polymerizing a cyclolefin in the presence of a filler treated with a norbornene-substituted silane coupling agent; boat and automobile reaction injection molded parts; rigidity; impact strength HERCULES INCORPORATED (US) 1991-10-08 US disclosed
EP-0439650-A1 Molded polymer article filled with inorganic material and production of said article HERCULES INCORPORATED (US) 1991-08-07 EP disclosed
EP-0329063-A2 Process for producing a colored molded article of metathesis polymerized polymer HERCULES INCORPORATED (US) 1989-08-23 EP disclosed
EP-0305933-A2 Process for producing a molded article of metathesis polymerized polymer HERCULES INCORPORATED (US) 1989-03-08 EP disclosed
US-4066683-A PROCESS FOR THE PREPARATION OF DIAMINOMALEONITRILE NIPPON CHEMICALS CO., LTD. (JA) 1978-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222351-A1 Process for producing compound, catalyst component for addition polymerization, process for producing catalyst for addition polymerization, and process for producing addition polymer CCNT1, C5, C9 TSHR 4243/4885THRB 3963/4885DNM1 3564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.